Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.90
Bid: 25.90
Ask: 26.20
Change: -0.60 (-2.26%)
Spread: 0.30 (1.158%)
Open: 26.35
High: 26.95
Low: 25.90
Prev. Close: 26.50
REVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Mar 2024 07:00

RNS Number : 4166I
Revolution Beauty Group PLC
27 March 2024
 

For immediate release

27 March 2024

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

Trading Update

Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, provides a trading update for the year ended 29 February 2024 ("FY 2024").

The Group has continued to deliver a strong operational performance and year-on-year improvement in profitability since its Capital Markets Event ("CME") and Trading Update on 8 February 2024. As a result, the Board now expects to report adjusted EBITDA of at least £12.5m and revenue growth of approximately 2% for FY 2024. This compares to the previous guidance of adjusted EBITDA of between £11m and £12m and revenue growth of low single digits.

As outlined at its CME, the Group is focusing on its Masterbrand, core categories and select geographies to deliver future growth. This strategy is progressing well, and whilst the exit of lower margin products and brands is causing a short-term impact on sales as expected, there is clear evidence that the longer-term benefit to profitability is already materialising. Coupled with the Group's £10m cost saving programme, which is progressing well, Revolution Beauty remains well-placed to deliver on its future growth ambitions.

The Group expects to report its FY 2024 results in June 2024. An update will be made nearer the time confirming the final date.

 

Lauren Brindley, Group Chief Executive Officer, commented: "It is early days, but we are already seeing positive impacts from the new strategy, including an encouraging response from our major customers and good progress on our cost savings programme. Our focus on driving sales from our more profitable brands is starting to deliver, with double-digit growth in sales of our core "Revolution" Masterbrand versus the second half of FY 2023.

"Our major product launches for 2024 are ahead of plan as we focus on fewer and more impactful new products. We also opened our TikTok shop this week and are preparing to go live with a new direct Amazon US partnership in May 2024. I remain highly confident about our growth prospects and our ability to become a top five mass beauty player."

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.

 

For further information, please contact:

 

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Liberum (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

 

Zeus: Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIIVEIRFIS
Date   Source Headline
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application
24th Jan 20247:00 amRNSNotice of Capital Markets Event
13th Dec 20237:00 amRNSDirectorate changes and settlement agreement
8th Dec 20237:00 amRNSChange of Adviser & Rule 17 Schedule Two(g) Update
27th Nov 20237:00 amRNSPress speculation
22nd Nov 20237:18 amRNSHolding(s) in Company
14th Nov 20231:29 pmRNSHolding(s) in Company
14th Nov 20231:25 pmRNSHolding(s) in Company
14th Nov 20231:23 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSInterim Results
9th Nov 20231:21 pmRNSNotice of Interim Results
31st Oct 20236:08 pmRNSHolding(s) in Company
31st Oct 20236:07 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSResults of AGM
19th Sep 20237:00 amRNSGrant of Share Options
13th Sep 20232:44 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of AGM and posting of Annual Report
4th Sep 20235:30 pmRNSHolding(s) in Company
4th Sep 20235:27 pmRNSHolding(s) in Company
31st Aug 20238:32 amRNSDirectorate Changes
31st Aug 20238:30 amRNSFINAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2023
21st Aug 20237:00 amRNSNotice of Results
7th Aug 202312:45 pmRNSGeneral Meeting Indefinitely Adjourned
24th Jul 20234:22 pmRNSHolding(s) in Company
21st Jul 20234:57 pmRNSRegulatory Investigation
21st Jul 20231:43 pmRNSPDMR Dealing
21st Jul 202310:58 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSWithdrawal of GM requisition & Board Updates
18th Jul 20237:00 amRNSSettlement Agreement with boohoo
10th Jul 20234:49 pmRNSNotice of General Meeting
5th Jul 202310:37 amRNSChange of registered office address
4th Jul 20232:09 pmRNSDirector dealings
3rd Jul 20234:30 pmRNSDirector dealings
30th Jun 20237:00 amRNSResponse to boohoo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.